Concepedia
Statistics
Publications
56
Citations
7.8K
H-Index
35
Active since
1994
Affiliations
University of Pittsburgh(Current)
UPMC Hillman Cancer Center
Inova Health System
St. Jude Children's Research Hospital
AstraZeneca (United Kingdom)
Christopher J. Bakkenist is an author at University of Pittsburgh specializing in medicine, cell biology, and molecular biology.
Top concepts
MedicineCell BiologyMolecular BiologyChromatinGenome InstabilityNatural SciencesOncologyCell CycleTumor BiologyCancer Research
Publications per year
1994–2023
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Christopher J. Bakkenist, Michael B. Kastan · Nature · 2003 · 3.4K citations
Chromatin, Genome Instability, Dna Damage +6
Phosphorylation of SMC1 is a critical downstream event in the ATM–NBS1–BRCA1 pathway
Risa Kitagawa, Christopher J. Bakkenist, Peter J. McKinnon et al. · Genes & Development · 2004 · 538 citations · Full text
Dna Damage, Genetics, Molecular Biology +22
The Telomeric Protein TRF2 Binds the ATM Kinase and Can Inhibit the ATM-Dependent DNA Damage Response
Jan Karlseder, Kristina Hoke, Olga K. Mirzoeva et al. · PLoS Biology · 2004 · 393 citations · Full text
Chromatin, Genome Instability, Dna Damage +13
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer<i>in vivo</i>
Frank P. Vendetti, Alan Lau, Sandra Schamus et al. · Oncotarget · 2015 · 235 citations · Full text
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation
Frank P. Vendetti, Pooja Karukonda, David A. Clump et al. · Journal of Clinical Investigation · 2018 · 202 citations · Full text
1–5 of 56